PATH | VRL
Menu

Find resources

Total results with these characteristics: 837

Resource type: Peer-reviewed journal

Page 42 of 42
Variation in Rotavirus Vaccine Coverage by Provider Location and Subsequent Disease Burden

This article, published in Pediatrics, reports on a study that examined variation in rotavirus vaccine coverage among provider locations in the United States and correlated coverage with the detection of rotavirus in children who sought treatment of …

Author: Sahni LC, Tate JE, Payne DC, Parashar UD, Boom JA

Publication date: 2015

Variation in the Costs of Delivering Routine Immunization Services in Peru

This paper, published in Bulletin of the World Health Organization, presents information on the variations in the costs of delivering routine immunization services in the three diverse districts of Peru. The study shows …

Author: Walker D, Mosqueira NR, Penny ME, et al.

Publication date: 2004

Vial Usage, Device Dead Space, Vaccine Wastage, and Dose Accuracy of Intradermal Delivery Devices for Inactivated Poliovirus Vaccine (IPV)

This article, published in Vaccine, reports the results of a study to assess different intradermal delivery devices for inactivated polio vaccine. Results showed wide variability between the devices in dead space, dose accuracy, overall wastage, and …

Author: Jarrahian C, Rein-Weston A, Saxon G, et al.

Publication date: 2017

Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

The authors of this article, published in the Journal of Virology, discuss the contributions of viral versus various host factors to respiratory syncytial virus (RSV) pathogenesis. The authors conclude that a better understanding of the viral and …

Author: Collins PL, Graham BS

Publication date: 2008

What Do the Next 100 Years Hold for Pneumococcal Vaccination?

This editorial article, published in Expert Review of Vaccines, provides a brief historical overview of vaccination against pneumococcal disease and offers a perspective on the future of pneumococcal vaccines. The authors describe the …

Author: Rijkers GT, van Mens SP, van Velzen-Blad H

Publication date: 2010

What Vaccine Product Attributes Do Immunization Program Stakeholders Value? Results From Interviews in Six Low- and Middle-Income Countries

This article, published in Vaccine, reports the results of a study that aimed to capture the opinions of stakeholders working in immunization programs in low- and middle-income countries in order to understand how vaccine products could be improved …

Author: Kristensen DD, Bartholomew K, Villadiego S, Lorenson K

Publication date: 2016

Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

Published in the journal Clinical Infectious Diseases, this study analyzed more than 70 recent data sets to compare the serogroups causing invasive pneumococcal disease with those represented in conjugate vaccine formulations. ABSTRACT ONLY. …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Publication date: 2000

WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016

This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease …

Author: Kobayashi M, Schrag SJ, Alderson MR, et al.

Publication date: 2016

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

WHO Initiative to Increase Global and Equitable Access to Influenza Vaccine in the Event of a Pandemic: Supporting Developing Country Production Capacity Through Technology Transfer

This article, published in Vaccine, showcases the interim results of the World Health Organization's technology transfer initiative to increase global and equitable access to influenza vaccine in the event of a pandemic. It highlights the progress …

Author: Friede M, Palkonyay L, Alfonso C, et al.

Publication date: 2011

WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of …

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Publication date: 2010

WHO Recommendations Regarding Vaccine Hesitancy

Vaccine hesitancy refers to delay in acceptance or refusal of safe vaccines despite availability of vaccination services. This special issue of Vaccine is guest-edited by the World Health Organization (WHO) and focuses on the topic of vaccine …

Author: Schuster M, Duclos P, eds.

Publication date: 2015

Whom and Where Are We Not Vaccinating? Coverage After the Introduction of a New Conjugate Vaccine Against Group A Meningococcus in Niger in 2010

The authors of this article, published in PLoS ONE, evaluated the first two phases of the introduction campaign of a new conjugate vaccine, MenAfriVac™, in Niger. They determined which sub-populations or areas …

Author: Kim SH, Pezzoli L, Yacouba H, et al.

Publication date: 2012

Will the Decade of Vaccines Mean Business as Usual?

The authors of this article, published in The Lancet, argue that anticipated advances in vaccinology during this new Decade of Vaccines (named by the Bill & Melinda Gates Foundation in January 2010) will only translate into reductions in …

Author: Rees H, Madhi SA

Publication date: 2011

Workshop on Vaccine Pressure and Neisseria Meningitidis, Annecy, France, 9-11 March 2005

This article, published in the journal Vaccine, summarizes a 2005 three-day workshop held in Annecy, France, that reviewed the current state of knowledge regarding Neisseria meningitidis capsule switching and vaccine pressure from capsular …

Author: Alonso JM, Gilmet G, Rouzic EM, et al.

Publication date: 2007

World Health Organization Definition of "Radiologically Confirmed Pneumonia" May Under-estimate the True Public Health Value of Conjugate Pneumococcal Vaccines

The public health benefit of conjugate pneumococcal vaccine (PCV) in preventing pneumonia would only be appreciated if the tool used for measuring “pneumococcal pneumonia” had good sensitivity. Exploratory studies in South Africa …

Author: Madhi S, Klugman K

Publication date: 2007

Page 42 of 42